News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

29,773 signal articles · 68 in last 24h · 148,348 total before filter · latest 1h ago

68last 24h

974last 7d

109● bullish (7d)

123● bearish (7d)

212publishers

All Macro369 Earnings115 M&A98 Regulatory8 Product11 Analyst10

✕ clear all filtersticker: GILDsentiment: bullishSentiment:bullish neutral bearish show all (incl. clickbait)

Insider Monkey83d agobullish

Gilead (GILD) Wins FDA Approval for Trodelvy in TNBC

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 12 Most Profitable S&P 500 Stocks to Invest In. On June 25, 2026, the Food and Drug Administration approved Trodelvy from Gilead Sciences, Inc. (NASDAQ:GILD) for two indications in adults with triple-negative breast cancer. The first approval covers sacituzumab govitecan-hziy as a single agent for the first-line […]

GILD MRK ^GSPC

Stocktwits119d agobullish

GILD Stock Jumps After Winning Accelerated FDA Approval For HDV Treatment

U.S. Food and Drug Administration (FDA) approved Hepcludex (bulevirtide-gmod) injection to treat chronic hepatitis delta virus.

GILD